Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-24

FDA Approved: CLOBAZAM — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for CLOBAZAM (clobazam) from Ascend Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)

Snippet

SUPPL AP for CLOBAZAM (CLOBAZAM)